Trial
NCT04920331
Study of Intravenous Erenumab in Patients With Status Migrainosus
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Status Migrainosus
Intervention
Erenumab
Why stopped
No Participants Enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-22